Back to GSKView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
10 competitors in Influenza
MRNAmRNA Flu vaccine
BNTXInfluenza and COVID-19 Combination A
Phase 3SNYA/H1N1 pandemic influenza vaccine (non- adjuvanted)
Phase 3NVSSurface Antigen, Inactivated, Adjuvanted, Influenza Vaccine, Formulation 2007-2008
Phase 2BNTXInvestigational COVID-19 Vaccine
Phase 2Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
FluoridePhase 3
Dental Caries
Combined Hepatitis A and B vaccinePhase 3
Hepatitis B
62.5/25mcgPhase 3
Pulmonary Disease, Chronic Obstructive
Losmapimod 7.5 mg twice dailyPhase 3
Acute Coronary Syndrome
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)Phase 3
Infections, Meningococcal
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts